# Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

> **NCT00132886** · PHASE2 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 140 (estimated)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** tolvaptan

## Key facts

- **NCT ID:** NCT00132886
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2012-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132886, "Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00132886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*